2008-10-01 |
2008-10-01 |
PS
Planned sale
|
Marco Philippe H
VP-QA, Clinical & Reg. Affairs
Officer
|
100
-0.1%
1.41
USD 141
|
100
-0.1%
|
1.41
|
USD 141
|
|
2008-10-01 |
2008-10-01 |
PS
Planned sale
|
Marco Philippe H
VP-QA, Clinical & Reg. Affairs
Officer
|
500
-0.7%
1.40
USD 700
|
500
-0.7%
|
1.40
|
USD 700
|
|
2008-10-01 |
2008-10-01 |
PS
Planned sale
|
Marco Philippe H
VP-QA, Clinical & Reg. Affairs
Officer
|
300
-0.4%
1.39
USD 417
|
300
-0.4%
|
1.39
|
USD 417
|
|
2008-10-01 |
2008-10-01 |
PS
Planned sale
|
Marco Philippe H
VP-QA, Clinical & Reg. Affairs
Officer
|
300
-0.4%
1.38
USD 414
|
300
-0.4%
|
1.38
|
USD 414
|
|
2008-10-01 |
2008-10-01 |
PS
Planned sale
|
Marco Philippe H
VP-QA, Clinical & Reg. Affairs
Officer
|
100
-0.1%
1.36
USD 136
|
100
-0.1%
|
1.36
|
USD 136
|
|
2008-10-01 |
2008-10-01 |
PS
Planned sale
|
Marco Philippe H
VP-QA, Clinical & Reg. Affairs
Officer
|
1,400
-1.9%
1.35
USD 1,890
|
1,400
-1.9%
|
1.35
|
USD 1,890
|
|
2008-10-01 |
2008-10-01 |
PS
Planned sale
|
Marco Philippe H
VP-QA, Clinical & Reg. Affairs
Officer
|
500
-0.7%
1.34
USD 670
|
500
-0.7%
|
1.34
|
USD 670
|
|
2008-10-01 |
2008-10-01 |
PS
Planned sale
|
Marco Philippe H
VP-QA, Clinical & Reg. Affairs
Officer
|
200
-0.3%
1.33
USD 266
|
200
-0.3%
|
1.33
|
USD 266
|
|
2008-10-01 |
2008-10-01 |
PS
Planned sale
|
Marco Philippe H
VP-QA, Clinical & Reg. Affairs
Officer
|
300
-0.4%
1.32
USD 396
|
300
-0.4%
|
1.32
|
USD 396
|
|
2008-10-01 |
2008-10-01 |
PS
Planned sale
|
Marco Philippe H
VP-QA, Clinical & Reg. Affairs
Officer
|
100
-0.1%
1.31
USD 131
|
100
-0.1%
|
1.31
|
USD 131
|
|
2008-10-01 |
2008-10-01 |
PS
Planned sale
|
Marco Philippe H
VP-QA, Clinical & Reg. Affairs
Officer
|
800
-1.1%
1.30
USD 1,040
|
800
-1.1%
|
1.30
|
USD 1,040
|
|
2008-10-01 |
2008-10-01 |
PS
Planned sale
|
Marco Philippe H
VP-QA, Clinical & Reg. Affairs
Officer
|
100
-0.1%
1.25
USD 125
|
100
-0.1%
|
1.25
|
USD 125
|
|
2008-09-02 |
2008-09-02 |
PS
Planned sale
|
Marco Philippe H
VP-QA, Clinical & Reg. Affairs
Officer
|
100
-0.1%
2.07
USD 207
|
100
-0.1%
|
2.07
|
USD 207
|
|
2008-09-02 |
2008-09-02 |
PS
Planned sale
|
Marco Philippe H
VP-QA, Clinical & Reg. Affairs
Officer
|
100
-0.1%
2.05
USD 205
|
100
-0.1%
|
2.05
|
USD 205
|
|
2008-09-02 |
2008-09-02 |
PS
Planned sale
|
Marco Philippe H
VP-QA, Clinical & Reg. Affairs
Officer
|
350
-0.5%
2.01
USD 704
|
350
-0.5%
|
2.01
|
USD 704
|
|
2008-09-02 |
2008-09-02 |
PS
Planned sale
|
Marco Philippe H
VP-QA, Clinical & Reg. Affairs
Officer
|
4,400
-5.5%
2.00
USD 8,800
|
4,400
-5.5%
|
2.00
|
USD 8,800
|
|
2008-08-04 |
2008-08-01 |
PS
Planned sale
|
Marco Philippe H
VP-QA, Clinical & Reg. Affairs
Officer
|
1,000
-1.2%
2.60
USD 2,600
|
1,000
-1.2%
|
2.60
|
USD 2,600
|
|
2008-08-04 |
2008-08-01 |
PS
Planned sale
|
Marco Philippe H
VP-QA, Clinical & Reg. Affairs
Officer
|
100
-0.1%
2.57
USD 257
|
100
-0.1%
|
2.57
|
USD 257
|
|
2008-08-04 |
2008-08-01 |
PS
Planned sale
|
Marco Philippe H
VP-QA, Clinical & Reg. Affairs
Officer
|
100
-0.1%
2.56
USD 256
|
100
-0.1%
|
2.56
|
USD 256
|
|
2008-08-04 |
2008-08-01 |
PS
Planned sale
|
Marco Philippe H
VP-QA, Clinical & Reg. Affairs
Officer
|
2,200
-2.6%
2.55
USD 5,610
|
2,200
-2.6%
|
2.55
|
USD 5,610
|
|
2008-06-03 |
2008-06-02 |
PS
Planned sale
|
Marco Philippe H
VP-QA, Clinical & Reg. Affairs
Officer
|
500
-0.6%
3.56
USD 1,780
|
500
-0.6%
|
3.56
|
USD 1,780
|
|
2008-06-03 |
2008-06-02 |
PS
Planned sale
|
Marco Philippe H
VP-QA, Clinical & Reg. Affairs
Officer
|
200
-0.2%
3.52
USD 704
|
200
-0.2%
|
3.52
|
USD 704
|
|
2008-06-03 |
2008-06-02 |
PS
Planned sale
|
Marco Philippe H
VP-QA, Clinical & Reg. Affairs
Officer
|
200
-0.2%
3.50
USD 700
|
200
-0.2%
|
3.50
|
USD 700
|
|
2008-06-03 |
2008-06-02 |
PS
Planned sale
|
Marco Philippe H
VP-QA, Clinical & Reg. Affairs
Officer
|
200
-0.2%
3.45
USD 690
|
200
-0.2%
|
3.45
|
USD 690
|
|
2008-06-03 |
2008-06-02 |
PS
Planned sale
|
Marco Philippe H
VP-QA, Clinical & Reg. Affairs
Officer
|
100
-0.1%
3.44
USD 344
|
100
-0.1%
|
3.44
|
USD 344
|
|
2008-06-03 |
2008-06-02 |
PS
Planned sale
|
Marco Philippe H
VP-QA, Clinical & Reg. Affairs
Officer
|
1,700
-1.9%
3.43
USD 5,831
|
1,700
-1.9%
|
3.43
|
USD 5,831
|
|
2008-06-03 |
2008-06-02 |
PS
Planned sale
|
Marco Philippe H
VP-QA, Clinical & Reg. Affairs
Officer
|
200
-0.2%
3.42
USD 684
|
200
-0.2%
|
3.42
|
USD 684
|
|
2008-04-24 |
2008-04-24 |
PS
Planned sale
|
Walsh Brian J
VP-Sales & Marketing
Officer
|
2,000
-4.3%
4.00
USD 8,000
|
2,000
-4.3%
|
4.00
|
USD 8,000
|
|
2008-04-24 |
2008-04-24 |
PS
Planned sale
|
Walsh Brian J
VP-Sales & Marketing
Officer
|
1,000
-2.1%
4.25
USD 4,250
|
1,000
-2.1%
|
4.25
|
USD 4,250
|
|
2008-04-24 |
2008-04-23 |
PS
Planned sale
|
Walsh Brian J
VP-Sales & Marketing
Officer
|
2,000
-4.1%
4.48
USD 8,960
|
2,000
-4.1%
|
4.48
|
USD 8,960
|
|
2008-04-02 |
2008-04-01 |
PS
Planned sale
|
Grainger Jeffry J
VP-Corp Affairs & Gen. Counsel
Officer
|
1,200
-1.1%
5.00
USD 6,000
|
1,200
-1.1%
|
5.00
|
USD 6,000
|
|
2008-04-02 |
2008-04-01 |
PS
Planned sale
|
Kahlenberg Timothy D
Chief Financial Officer
Officer
|
798
-100.0%
5.05
USD 4,030
|
798
-100.0%
|
5.05
|
USD 4,030
|
|
2008-04-02 |
2008-04-01 |
PS
Planned sale
|
Kahlenberg Timothy D
Chief Financial Officer
Officer
|
202
-100.0%
5.00
USD 1,010
|
202
-100.0%
|
5.00
|
USD 1,010
|
|
2008-04-02 |
2008-04-01 |
PS
Planned sale
|
Casciaro Gregory D
President and CEO
Executive Director
|
1,198
-0.2%
5.00
USD 5,990
|
1,198
-0.2%
|
5.00
|
USD 5,990
|
|
2008-03-05 |
2008-03-03 |
PS
Planned sale
|
Casciaro Gregory D
President and CEO
Executive Director
|
300
-0.0%
6.85
USD 2,055
|
300
-0.0%
|
6.85
|
USD 2,055
|
|
2008-03-05 |
2008-03-03 |
PS
Planned sale
|
Casciaro Gregory D
President and CEO
Executive Director
|
566
-0.1%
6.86
USD 3,883
|
566
-0.1%
|
6.86
|
USD 3,883
|
|
2008-03-05 |
2008-03-03 |
PS
Planned sale
|
Casciaro Gregory D
President and CEO
Executive Director
|
201
-0.0%
6.87
USD 1,381
|
201
-0.0%
|
6.87
|
USD 1,381
|
|
2008-03-05 |
2008-03-03 |
PS
Planned sale
|
Casciaro Gregory D
President and CEO
Executive Director
|
199
-0.0%
6.90
USD 1,373
|
199
-0.0%
|
6.90
|
USD 1,373
|
|
2008-03-05 |
2008-03-03 |
PS
Planned sale
|
Casciaro Gregory D
President and CEO
Executive Director
|
33
-0.0%
6.91
USD 228
|
33
-0.0%
|
6.91
|
USD 228
|
|
2008-03-05 |
2008-03-03 |
PS
Planned sale
|
Casciaro Gregory D
President and CEO
Executive Director
|
33
-0.0%
6.94
USD 229
|
33
-0.0%
|
6.94
|
USD 229
|
|
2008-03-05 |
2008-03-03 |
PS
Planned sale
|
Casciaro Gregory D
President and CEO
Executive Director
|
66
-0.0%
6.95
USD 459
|
66
-0.0%
|
6.95
|
USD 459
|
|
2008-03-05 |
2008-03-03 |
PS
Planned sale
|
Casciaro Gregory D
President and CEO
Executive Director
|
201
-0.0%
6.98
USD 1,403
|
201
-0.0%
|
6.98
|
USD 1,403
|
|
2008-03-05 |
2008-03-03 |
PS
Planned sale
|
Casciaro Gregory D
President and CEO
Executive Director
|
201
-0.0%
7.46
USD 1,499
|
201
-0.0%
|
7.46
|
USD 1,499
|
|
2008-03-05 |
2008-03-03 |
PS
Planned sale
|
Casciaro Gregory D
President and CEO
Executive Director
|
67
-0.0%
7.50
USD 503
|
67
-0.0%
|
7.50
|
USD 503
|
|
2008-03-04 |
2008-03-03 |
PS
Planned sale
|
Grainger Jeffry J
VP-Corp Affairs & Gen. Counsel
Officer
|
300
-0.3%
6.85
USD 2,055
|
300
-0.3%
|
6.85
|
USD 2,055
|
|
2008-03-04 |
2008-03-03 |
PS
Planned sale
|
Grainger Jeffry J
VP-Corp Affairs & Gen. Counsel
Officer
|
3,066
-2.6%
6.86
USD 21,033
|
3,066
-2.6%
|
6.86
|
USD 21,033
|
|
2008-03-04 |
2008-03-03 |
PS
Planned sale
|
Grainger Jeffry J
VP-Corp Affairs & Gen. Counsel
Officer
|
700
-0.6%
6.87
USD 4,809
|
700
-0.6%
|
6.87
|
USD 4,809
|
|
2008-03-04 |
2008-03-03 |
PS
Planned sale
|
Grainger Jeffry J
VP-Corp Affairs & Gen. Counsel
Officer
|
200
-0.2%
6.90
USD 1,380
|
200
-0.2%
|
6.90
|
USD 1,380
|
|
2008-03-04 |
2008-03-03 |
PS
Planned sale
|
Grainger Jeffry J
VP-Corp Affairs & Gen. Counsel
Officer
|
34
-0.0%
6.91
USD 235
|
34
-0.0%
|
6.91
|
USD 235
|
|
2008-03-04 |
2008-03-03 |
PS
Planned sale
|
Grainger Jeffry J
VP-Corp Affairs & Gen. Counsel
Officer
|
34
-0.0%
6.94
USD 236
|
34
-0.0%
|
6.94
|
USD 236
|
|
2008-03-04 |
2008-03-03 |
PS
Planned sale
|
Grainger Jeffry J
VP-Corp Affairs & Gen. Counsel
Officer
|
67
-0.1%
6.95
USD 466
|
67
-0.1%
|
6.95
|
USD 466
|
|
2008-03-04 |
2008-03-03 |
PS
Planned sale
|
Grainger Jeffry J
VP-Corp Affairs & Gen. Counsel
Officer
|
200
-0.2%
6.98
USD 1,396
|
200
-0.2%
|
6.98
|
USD 1,396
|
|
2008-03-04 |
2008-03-03 |
PS
Planned sale
|
Grainger Jeffry J
VP-Corp Affairs & Gen. Counsel
Officer
|
200
-0.2%
7.46
USD 1,492
|
200
-0.2%
|
7.46
|
USD 1,492
|
|
2008-03-04 |
2008-03-03 |
PS
Planned sale
|
Grainger Jeffry J
VP-Corp Affairs & Gen. Counsel
Officer
|
66
-0.1%
7.50
USD 495
|
66
-0.1%
|
7.50
|
USD 495
|
|
2008-03-04 |
2008-03-03 |
PS
Planned sale
|
Marco Philippe H
VP-QA, Clinical & Reg. Affairs
Officer
|
100
-0.1%
7.49
USD 749
|
100
-0.1%
|
7.49
|
USD 749
|
|
2008-03-04 |
2008-03-03 |
PS
Planned sale
|
Marco Philippe H
VP-QA, Clinical & Reg. Affairs
Officer
|
100
-0.1%
7.30
USD 730
|
100
-0.1%
|
7.30
|
USD 730
|
|
2008-03-04 |
2008-03-03 |
PS
Planned sale
|
Marco Philippe H
VP-QA, Clinical & Reg. Affairs
Officer
|
100
-0.1%
7.18
USD 718
|
100
-0.1%
|
7.18
|
USD 718
|
|
2008-03-04 |
2008-03-03 |
PS
Planned sale
|
Marco Philippe H
VP-QA, Clinical & Reg. Affairs
Officer
|
300
-0.3%
7.16
USD 2,148
|
300
-0.3%
|
7.16
|
USD 2,148
|
|
2008-03-04 |
2008-03-03 |
PS
Planned sale
|
Marco Philippe H
VP-QA, Clinical & Reg. Affairs
Officer
|
200
-0.2%
7.15
USD 1,430
|
200
-0.2%
|
7.15
|
USD 1,430
|
|
2008-03-04 |
2008-03-03 |
PS
Planned sale
|
Marco Philippe H
VP-QA, Clinical & Reg. Affairs
Officer
|
200
-0.2%
7.14
USD 1,428
|
200
-0.2%
|
7.14
|
USD 1,428
|
|
2008-03-04 |
2008-03-03 |
PS
Planned sale
|
Marco Philippe H
VP-QA, Clinical & Reg. Affairs
Officer
|
200
-0.2%
7.12
USD 1,424
|
200
-0.2%
|
7.12
|
USD 1,424
|
|
2008-03-04 |
2008-03-03 |
PS
Planned sale
|
Marco Philippe H
VP-QA, Clinical & Reg. Affairs
Officer
|
400
-0.4%
7.11
USD 2,844
|
400
-0.4%
|
7.11
|
USD 2,844
|
|
2008-03-04 |
2008-03-03 |
PS
Planned sale
|
Marco Philippe H
VP-QA, Clinical & Reg. Affairs
Officer
|
100
-0.1%
7.10
USD 710
|
100
-0.1%
|
7.10
|
USD 710
|
|
2008-03-04 |
2008-03-03 |
PS
Planned sale
|
Marco Philippe H
VP-QA, Clinical & Reg. Affairs
Officer
|
100
-0.1%
7.07
USD 707
|
100
-0.1%
|
7.07
|
USD 707
|
|
2008-03-04 |
2008-03-03 |
PS
Planned sale
|
Marco Philippe H
VP-QA, Clinical & Reg. Affairs
Officer
|
100
-0.1%
7.06
USD 706
|
100
-0.1%
|
7.06
|
USD 706
|
|
2008-03-04 |
2008-03-03 |
PS
Planned sale
|
Marco Philippe H
VP-QA, Clinical & Reg. Affairs
Officer
|
200
-0.2%
7.01
USD 1,402
|
200
-0.2%
|
7.01
|
USD 1,402
|
|
2008-03-04 |
2008-03-03 |
PS
Planned sale
|
Marco Philippe H
VP-QA, Clinical & Reg. Affairs
Officer
|
300
-0.3%
7.00
USD 2,100
|
300
-0.3%
|
7.00
|
USD 2,100
|
|
2008-03-04 |
2008-03-03 |
PS
Planned sale
|
Marco Philippe H
VP-QA, Clinical & Reg. Affairs
Officer
|
200
-0.2%
6.95
USD 1,390
|
200
-0.2%
|
6.95
|
USD 1,390
|
|
2008-03-04 |
2008-03-03 |
PS
Planned sale
|
Marco Philippe H
VP-QA, Clinical & Reg. Affairs
Officer
|
100
-0.1%
6.93
USD 693
|
100
-0.1%
|
6.93
|
USD 693
|
|
2008-03-04 |
2008-03-03 |
PS
Planned sale
|
Marco Philippe H
VP-QA, Clinical & Reg. Affairs
Officer
|
100
-0.1%
6.89
USD 689
|
100
-0.1%
|
6.89
|
USD 689
|
|
2008-03-04 |
2008-03-03 |
PS
Planned sale
|
Marco Philippe H
VP-QA, Clinical & Reg. Affairs
Officer
|
100
-0.1%
6.87
USD 687
|
100
-0.1%
|
6.87
|
USD 687
|
|
2008-03-04 |
2008-03-03 |
PS
Planned sale
|
Marco Philippe H
VP-QA, Clinical & Reg. Affairs
Officer
|
400
-0.4%
6.86
USD 2,744
|
400
-0.4%
|
6.86
|
USD 2,744
|
|
2008-03-04 |
2008-03-03 |
PS
Planned sale
|
Marco Philippe H
VP-QA, Clinical & Reg. Affairs
Officer
|
100
-0.1%
6.85
USD 685
|
100
-0.1%
|
6.85
|
USD 685
|
|
2008-03-04 |
2008-03-03 |
PS
Planned sale
|
Kahlenberg Timothy D
Chief Financial Officer
Officer
|
68
-100.0%
6.86
USD 466
|
68
-100.0%
|
6.86
|
USD 466
|
|
2008-03-04 |
2008-03-03 |
PS
Planned sale
|
Kahlenberg Timothy D
Chief Financial Officer
Officer
|
201
-74.7%
6.90
USD 1,387
|
201
-74.7%
|
6.90
|
USD 1,387
|
|